Skip to main content
. 2022 Jan 28;8:803600. doi: 10.3389/fmed.2021.803600

Table 2.

Frequency of proven/probable fungal infections with regard to type of therapy.

Empirical Preemptive Total (%)
Probable IFIs positive, N (%) 9 (11.25%) 11 (13.75%)
IFIs negative, N (%) 31 (38.75%) 29 (36.25%)
Proven IFIs positive, N (%) 6 (7.50%) Mucormycosis 3 (20.00%) 9 (11.25%) Mucormycosis 5 (33.33%)
Aspergillosis 3 (20.00%) Aspergillosis 4 (26.67%)
IFIs negative, N (%) 34 (42.50%) 31 (38.75%)
Total (%) 40 (50.00%) 40 (50.00%) 80 (100%)